Welcome to Francis Academic Press

Academic Journal of Medicine & Health Sciences, 2020, 1(1); doi: 10.25236/AJMHS.2020.010103.

The clinical efficacy of HPV, TCT and colposcopy in cervical cancer screening

Author(s)

Luo Jianwei

Corresponding Author:
Luo Jianwei
Affiliation(s)

Leshan vocational and Technical College, Leshan, 614000, China

Abstract

[Objective] To analyze the clinical efficacy of HPV, TCT combined with colposcopy in cervical cancer screening. [Methods] This study took 1,400 patients admitted to our hospital as the study object, and used the liquid-based thin layer cytology test, and human papilloma virus-DNA detection and colposcopy, taking the histopathological results of cervical biopsy as the diagnostic criteria, evaluate the effect of combined detection on the early diagnosis of cervical cancer. [Results] The results of this study showed that among 1400 patients, the liquid-based thin layer cytology test positive rate was 17.63%, and the lesion detection rate was 79.04%. The detection rate of human papilloma virus-DNA testing for squamous cell carcinoma is as high as 100%. The positive rate of detection was 50.86%, and the detection rate of lesions reached 85.62%. The detection rate of liquid-based thin layer cytology test and human papilloma virus-DNA combined with colposcopy for cervical lesions is 100%, which can effectively reduce the missed diagnosis rate, and the detection rate is significantly increased. [Conclusion] The clinical use of HPV-DNA, liquid-based cytology and colposcopy for early screening of cervical cancer is an efficient and feasible program, which can increase the detection rate of cervical precancerous lesions and reduce the missed diagnosis rate. It is great significance for cervical cancer screening.

Keywords

Cervical cancer screening; HPV; TCT; Colposcopy

Cite This Paper

Luo Jianwei. The clinical efficacy of HPV, TCT and colposcopy in cervical cancer screening. Academic Journal of Medicine & Health Sciences (2020) Vol. 1, Issue 1: 20-25. https://doi.org/10.25236/AJMHS.2020.010103.

References

[1] Tu Kaifeng. Study on the age of onset and the changing trend of etiology  in cervical cancer [J]. Modern Medicine and Health Research, 2018, 000(005):181-181.
[2] Chai Chunjing. Analysis  80 young cervical cancer patients about clinical characteristics, postoperative recurrence and prognostic factors [J]. Chinese and Foreign Women's Health Research, 2018, 000(014):118,143.
[3] Wu Cuixia, Zhang Yanhong, Ge Xiaohua, et al. Study on the correlation between high-risk HPV infection and cervical precancerous lesions and cervical cancer[J]. Chinese Journal of Nosocomiology, 2016, 26(011):2568-2570.
[4] Bao Juan. The significance of prevention and treatment of chronic cervicitis in preventing cervical cancer[J]. Journal of Practical Gynecology and Endocrinology (Electronic Edition), 2018.
[5] Han Hua, Chen Wenyue. Study on the correlation of vaginal flora with HPV infection CIN and cervical cancer [J]. Zhejiang Medicine, 2018, 040(007):745-746,755.